Just - Evotec Biologics

About:

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Website: http://www.justbiotherapeutics.com/

Top Investors: ARCH Venture Partners, Bill & Melinda Gates Foundation, Merck, Lilly Asia Ventures

Description:

Just Evotec Biologics was founded in 2014 and acquired by Evotec in 2019. The company has an intense focus on the design of innovative and integrated technologies to accelerate the development of biotherapeutics and reduce their manufacturing cost. Core strengths include antibody discovery, molecular design, process and product design and manufacturing plant design.

Total Funding Amount:

$29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2014-01-01

Contact Email:

media(AT)just.bio

Founders:

Dean K. Pettit, James N. Thomas, Ph.D., Victor P. Fung

Number of Employees:

251-500

Last Funding Date:

2016-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai